Literature DB >> 19901029

SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.

Stephanie Hammerich-Hille1, Benny A Kaipparettu, Anna Tsimelzon, Chad J Creighton, Shiming Jiang, Jose M Polo, Ari Melnick, Rene Meyer, Steffi Oesterreich.   

Abstract

The scaffold attachment factors SAFB1 and SAFB2 are paralogs, which are involved in cell cycle regulation, apoptosis, differentiation, and stress response. They have been shown to function as estrogen receptor corepressors, and there is evidence for a role in breast tumorigenesis. To identify their endogenous target genes in MCF-7 breast cancer cells, we utilized a combined approach of chromatin immunoprecipitation (ChIP)-on-chip and gene expression array studies. By performing ChIP-on-chip on microarrays containing 24,000 promoters, we identified 541 SAFB1/SAFB2-binding sites in promoters of known genes, with significant enrichment on chromosomes 1 and 6. Gene expression analysis revealed that the majority of target genes were induced in the absence of SAFB1 or SAFB2 and less were repressed. Interestingly, there was no significant overlap between the genes identified by ChIP-on-chip and gene expression array analysis, suggesting regulation through regions outside the proximal promoters. In contrast to SAFB2, which shared most of its target genes with SAFB1, SAFB1 had many unique target genes, most of them involved in the regulation of the immune system. A subsequent analysis of the estrogen treatment group revealed that 12% of estrogen-regulated genes were dependent on SAFB1, with the majority being estrogen-repressed genes. These were primarily genes involved in apoptosis, such as BBC3, NEDD9, and OPG. Thus, this study confirms the primary role of SAFB1/SAFB2 as corepressors and also uncovers a previously unknown role for SAFB1 in the regulation of immune genes and in estrogen-mediated repression of genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901029      PMCID: PMC2823501          DOI: 10.1074/jbc.M109.066431

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

3.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

Authors:  John R Jeffers; Evan Parganas; Youngsoo Lee; Chunying Yang; JinLing Wang; Jennifer Brennan; Kirsteen H MacLean; Jiawen Han; Thomas Chittenden; James N Ihle; Peter J McKinnon; John L Cleveland; Gerard P Zambetti
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

4.  Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.

Authors:  S Oesterreich; Q Zhang; T Hopp; S A Fuqua; M Michaelis; H H Zhao; J R Davie; C K Osborne; A V Lee
Journal:  Mol Endocrinol       Date:  2000-03

5.  HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.

Authors:  S M Townson; T Sullivan; Q Zhang; G M Clark; C K Osborne; A V Lee; S Oesterreich
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

6.  SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.

Authors:  Steven M Townson; Klaudia M Dobrzycka; Adrian V Lee; Mamie Air; Wanleng Deng; Kaiyan Kang; Shiming Jiang; Noriyuki Kioka; Kai Michaelis; Steffi Oesterreich
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

7.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

8.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

Authors:  Jonna Frasor; Jeanne M Danes; Barry Komm; Ken C N Chang; C Richard Lyttle; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2003-07-10       Impact factor: 4.736

9.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.

Authors:  S Oesterreich; D C Allredl; S K Mohsin; Q Zhang; H Wong; A V Lee; C K Osborne; P O'Connell
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

View more
  15 in total

1.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

Review 2.  Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.

Authors:  Stéphanie Légaré; Mark Basik
Journal:  Mol Endocrinol       Date:  2016-07-20

Review 3.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

4.  Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane association.

Authors:  Mo Zhou; Leena Kuruvilla; Xiarong Shi; Stephen Viviano; Ian M Ahearn; Caroline R Amendola; Wenjuan Su; Sana Badri; James Mahaffey; Nicole Fehrenbacher; Jane Skok; Joseph Schlessinger; Benjamin E Turk; David A Calderwood; Mark R Philips
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-30       Impact factor: 11.205

5.  Co-repressor activity of scaffold attachment factor B1 requires sumoylation.

Authors:  Jason P Garee; Rene Meyer; Steffi Oesterreich
Journal:  Biochem Biophys Res Commun       Date:  2011-04-19       Impact factor: 3.575

6.  Drosophila SAF-B links the nuclear matrix, chromosomes, and transcriptional activity.

Authors:  Catalina Alfonso-Parra; Keith A Maggert
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

7.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

8.  Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.

Authors:  N K Mukhopadhyay; J Kim; S You; M Morello; M H Hager; W-C Huang; A Ramachandran; J Yang; B Cinar; M A Rubin; R M Adam; S Oesterreich; D Di Vizio; M R Freeman
Journal:  Oncogene       Date:  2013-07-29       Impact factor: 9.867

9.  Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells.

Authors:  Elaine Hong; Andrew Best; Hannah Gautrey; Jas Chin; Anshuli Razdan; Tomaz Curk; David J Elliott; Alison J Tyson-Capper
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

10.  The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.

Authors:  J Manuel Hernández-Hernández; Chandrashekara Mallappa; Brian T Nasipak; Steffi Oesterreich; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.